AI summary · may contain errors
Baveno VIII consensus updated guidance for advanced chronic liver disease and portal hypertension, with 272 statements and recommendations reaching strong consensus (>80% agreement).
- 1 cited this week
- Open access
Moving in Gut, Hepatology and Journal of Hepatology.
Rebuilt
AI summary · may contain errors
Baveno VIII consensus updated guidance for advanced chronic liver disease and portal hypertension, with 272 statements and recommendations reaching strong consensus (>80% agreement).
AI summary · may contain errors
Ambulatory adults with cirrhosis awaiting liver transplantation lost skeletal muscle at a median rate of -1.6% per year, with rapid loss defined as < -7.4%/year.
Newest first · last 60 days
AI summary · may contain errors
Aquitalea magnusonii translocation across the intestinal barrier is linked to systemic inflammation and liver fibrosis in chronic liver disease models, including ACLF-associated metabolite production.
AI summary · may contain errors
Non-invasive tests can predict clinically meaningful decompensation outcomes in compensated advanced chronic liver disease with prognostic accuracy comparable to hepatic venous pressure gradient (HVPG) measurement.
AI summary · may contain errors
In 7,040 hospitalized cirrhosis patients worldwide, chronic kidney disease is present in 18.17%, with the highest prevalence in high-income countries.
AI summary · may contain errors
CiRPM after hospitalization for acutely decompensated cirrhosis is linked to fewer 90-day liver-related readmissions versus C-control (39% vs 58%, HR 0.57, p=0.01).
AI summary · may contain errors
Hepatopulmonary syndrome and portopulmonary hypertension are distinct pulmonary vascular complications in liver transplantation candidates, and both substantially increase morbidity and mortality.
AI summary · may contain errors
In 221 outpatients with cirrhosis across USA, Denmark, Lithuania, and Mexico, worse PHES performance is linked to a distinct microbiome signature with higher Streptococcus abundance.
AI summary · may contain errors
Oral YAQ007 lowered ammonia by day 5 in cirrhosis patients with prior overt hepatic encephalopathy, with significant reductions at 4 g twice daily and 4 g three times daily.
AI summary · may contain errors
Baveno VIII consensus updated guidance for advanced chronic liver disease and portal hypertension, with 272 statements and recommendations reaching strong consensus (>80% agreement).
AI summary · may contain errors
Fibrosis regression in chronic liver disease can substantially disappear or be remodelled, and even established cirrhosis reversal has been documented, but clinical significance of regressive histology remains largely unstudied.
AI summary · may contain errors
A pan-elastography machine-learning ELM score predicts clinically significant portal hypertension in compensated advanced chronic liver disease with external AUC 0.91 and reduced the gray zone to 12.3%.
AI summary · may contain errors
Anserine supplementation restores antibacterial immunity in cirrhotic mice by reconstituting hepatocyte CCL5–mediated recruitment of CD44+ plasmacytoid dendritic cells, reducing bacterial burden and mortality.
AI summary · may contain errors
In a multinational prospective cohort of hospitalized alcohol-associated hepatitis patients, metabolic dysfunction and cardiometabolic risk factors were not linked to higher 180-day mortality, while age, alcohol intake, MELD, and ACLF grade predicted death.
AI summary · may contain errors
In a national cohort of Veterans with cirrhosis undergoing 56,941 outpatient paracenteses, i.v. albumin use (17%) was linked to lower AKI-related hospitalization odds (OR 0.66).
AI summary · may contain errors
In a multicenter trial of 89 patients with severe alcohol-associated hepatitis (MELD≥20), IL-1Ra treatment drove a day-7 IL-1Ra rise and broader cytokine shifts, while steroid therapy showed IL-1β elevation by day 28.
Journals this month
Topics moving, week to 17 Nov 2026
By field